The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials

Authors
Publication date
1 January 2021
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Cronfa at Swansea University

      redirect
      oaioai:cronfa.swan.ac.uk:cronfa55...
      Last time updated on 03/12/2020